• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Self-reported HPV vaccination and vaccination record linkage in the Australian Oral Diversity Study
CONCLUSION: We found that the correlation between self-reported Gardasil® vaccination and the AIR records were very good, with high sensitivity and specificity.PMID:37256380 | DOI:10.1007/s10552-023-01729-4
Source: Cancer Control - May 31, 2023 Category: Cancer & Oncology Authors: Annika Antonsson Source Type: research

Pregnancy-associated gynecological cancer in New South Wales, Australia 1994-2013: A population-based historical cohort study
CONCLUSIONS: The incidence of PAGC has not increased over time perhaps reflecting, in part, the effectiveness of cervical screening and early impacts of human papillomavirus vaccination programs in Australia. The higher rate of preterm birth among the gestational PAGC group is associated with adverse outcomes in babies born to these women.PMID:36915236 | DOI:10.1111/aogs.14530
Source: Cancer Control - March 14, 2023 Category: Cancer & Oncology Authors: Penelope Fotheringham Nadom Safi Zhouyang Li Antoinette Anazodo Marc Remond Andrew Hayen David Currow David Roder Nada Hamad Michael Nicholl Adrienne Gordon Jane Frawley Elizabeth A Sullivan Source Type: research

Disparities in Human Papillomavirus vaccination coverage among adolescents in Australia: A geospatial analysis
CONCLUSION: Socioeconomic and education factors were important predictors for HPV vaccination rates among Australian boys and girls aged 15 years, although no variable presented a uniform effect on HPV vaccination across SA4 regions. Important spatial heterogeneity in the effect of predictors was identified across the study area.PMID:35750540 | DOI:10.1016/j.vaccine.2022.06.030
Source: Vaccine - June 24, 2022 Category: Allergy & Immunology Authors: Gustavo Hermes Soares Sneha Sethi Joanne Hedges Lisa Jamieson Source Type: research

HPV vaccination coverage: slightly improved two-dose schedule completion estimates and historical estimates lower on AIR than HPV Register
CONCLUSIONS: Coverage is slightly lower using AIR than HPV register estimates. Moving from three to two doses has slightly improved completion, likely due to the wider dose spacing, but equity gaps remain.IMPLICATIONS FOR PUBLIC HEALTH: An ongoing focus on equity in vaccine delivery is needed. Systems, reminders and catch-up opportunities to ensure course completion remain important.PMID:35357729 | DOI:10.1111/1753-6405.13233
Source: Australian and New Zealand Journal of Public Health - March 31, 2022 Category: International Medicine & Public Health Authors: Julia Brotherton Alexandra Hendry Aditi Dey Brynley P Hull Frank Beard Source Type: research

Exploring electronic health records to estimate the extent of catch-up immunisation and factors associated with under-immunisation among refugees and asylum seekers in south east Queensland
CONCLUSION: This study indicates that the broader group of immigrants, and in particular refugees and asylum seekers, do not represent a homogenous group in terms of immunisation coverage, and that each cohort should be carefully considered during immunisation interventions and strategies. This will be particularly important during targeted health promotions and future immunisation programs in this cohort.PMID:34556368 | DOI:10.1016/j.vaccine.2021.09.026
Source: Vaccine - September 24, 2021 Category: Allergy & Immunology Authors: Mercy Moraa Nyanchoga Patricia Lee Gaery Barbery Source Type: research

Human papillomavirus prevalence and risk factors among Australian women 9-12  years after vaccine program introduction
CONCLUSION: Vaccination has changed the epidemiology of HPV infection in Australian women, having markedly reduced the prevalence of vaccine-targeted types, including amongst women with known risk factors for infection. Vaccinated women appear to be benefiting from modest cross-protection against types 31/33/45 afforded by the quadrivalent HPV vaccine. These results reinforce the importance of HPV vaccination.PMID:34281743 | DOI:10.1016/j.vaccine.2021.07.005
Source: Vaccine - July 20, 2021 Category: Allergy & Immunology Authors: Hannah Shilling Suzanne M Garland Steph Atchison Alyssa M Cornall Julia M L Brotherton Deborah Bateson Kathleen McNamee John M Kaldor Jane S Hocking Marcus Y Chen Christopher K Fairley Anna McNulty Charlotte Bell Lewis Marshall Catriona Ooi S Rachel Skinn Source Type: research

Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer
Basel, 16 September 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval for the expanded use of CINtec®PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results are positive for high-risk types of human papillomavirus (HPV). Additional information from this test supports clinical decisions about which women will benefit most from immediate follow-up. Laboratories can now use CINtecPLUS Cytology to triage positive results from the cobas ® HPV Test run on the fully integrated, automated and high-throughput co...
Source: Roche Media News - September 16, 2020 Category: Pharmaceuticals Source Type: news